Revvity | PKI - Ativo Circulante





Ativo Circulante Alterar Data
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Celltrion KRW 481.57B 10.97B 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Illumina USD 2.74B 551M 2026-03
Intuitive Surgical USD 12.33B 807.5M 2026-06
IQVIA Holdings USD 6.22B 29M 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
OraSure Technologies USD 240.78M 21.13M 2026-03
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Tilray USD 729.32M 28.18M 2025-09
Waters USD 3.72B 1.73B 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03